IMG-7289

Generic Name: IMG-7289

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₃₄FN_₇O_₂

CAS Number: 1990504-34-1

Unique Ingredient Identifier: -

Background: IMG-7289 is under investigation in clinical trial NCT03136185 (IMG-7289 in Patients With Myelofibrosis).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

IMG-7289 in Patients with Essential Thrombocythemia (ET) or Polycythemia Vera (PV)

Phase 2

Active, not recruiting

Conditions: Essential Thrombocythemia
Polycythemia Vera

Interventions: Drug: IMG-7289

First Posted Date: 2020-02-10

Last Posted Date: 2024-12-17

Lead Sponsor: Terrence J Bradley, MD

Target Recruit Count: 4

Registration Number: NCT04262141

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2

Phase 2

Active, not recruiting

Conditions: Thrombocythemia, Essential

Interventions: Drug: IMG-7289

First Posted Date: 2019-09-09

Last Posted Date: 2024-07-09

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 9

Registration Number: NCT04081220

Locations: 🇺🇸
Mays Cancer Center, San Antonio, Texas, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy